FDA 483 - Laurel Fertility Care, A Professional Medical Corporation - February 07, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Laurel Fertility Care, a reproductive tissue establishment in San Francisco, revealed two observations. The firm failed to determine HCT/P donor eligibility based on complete screening and testing, specifically processing oocyte donors before reviewing all relevant communicable disease agent or disease testing records. Additionally, donor eligibility records were found to be neither indelible nor legible, with instances of ink obliteration and overwriting.
- Inspection Date
- February 7, 2023
- Product Type
- Biologics
ID · 277d444a-dd5d-447f-b026-1a0ffd3b9fad